Chu NV, Kong APS, Kim DD, Armstrong D, Baxi S, Deutsch R, Caulfield M, Mudaliar SR, Reitz R, Henry RR, Reaven PD: Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care25:542–549, 2002
The authors of the above-listed article would like to make the following changes:
On page 542, in the results section of the abstract, the units for C- reactive protein (CRP) should be mg/l instead of ng/l.
On page 546, second column, 15 lines from the bottom, the HDL increase should be given as 11% instead of 9%. The correct sentence is as follows: “Changes in the lipid levels were more favorable in the troglitazone group: triglyceride levels decreased by 21% and HDL increased by 11%.”
2002
